Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Tetralone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113563167B reveals a high-yield 2-methyl-1-tetralone method. This process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Grignard-based route for 6-methoxy-1-tetralone avoids high-pressure hydrogenation. Enhances purity and supply chain reliability for steroid API production.
Efficient one-step coupling method for 1-aryl-2-tetralones using ferrocene-palladium catalysts. Reduces synthetic steps and improves regioselectivity for pharmaceutical intermediates.
Novel patent CN117466723A enables safer halogenated tetralone production. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Patent CN106977377B reveals a one-pot Lewis acid method for 7-hydroxy-1-tetralone, offering high purity and eliminating phosphorus waste for reliable pharmaceutical intermediate supply chains.
Patent CN101792400A details a high-yield four-step route for Agomelatine, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel one-pot Friedel-Crafts route for 6-methoxy-1-tetralone. High yield, low cost, scalable steroid intermediate manufacturing avoiding toxic chromium reagents.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN116730810A reveals high-yield synthesis for steroid intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel copper-catalyzed one-step synthesis of 3,4-cyclopentyl-1-tetralone. Reduces steps, improves yield, ensures supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105936623B reveals a mild copper-catalyzed route to 3,4-cyclopentyl-1-tetralone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.